Premium
Study finds some unendorsed practices in first‐episode schizophrenia prescribing
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30026
Subject(s) - schizophrenia (object oriented programming) , psychiatry , medicine , medical prescription , depression (economics) , antidepressant , antipsychotic , anxiety , pharmacology , economics , macroeconomics
Nearly 40% of a group of 404 participants in a first‐episode schizophrenia study were evaluated as possibly benefiting from a change in their psychotropic prescriptions, with issues such as some patients receiving more than one antipsychotic or receiving an antidepressant despite a lack of a depression indication. The study results, published online Dec. 4, 2014, in the American Journal of Psychiatry , suggest that some prescribers do not tailor their medication decision‐making to the specific needs of first‐episode schizophrenia patients, as recommended in schizophrenia treatment practice guidelines.